血清降钙素原检测对肝衰竭合并感染的早期诊断价值

王传敏; 孟忠吉; 陈悦; 刘莉

doi:10.3969/j.issn.1001-5256.2017.06.024

血清降钙素原检测对肝衰竭合并感染的早期诊断价值

DOI: 10.3969/j.issn.1001-5256.2017.06.024

湖北省十堰市太和医院湖北医药学院附属医院感染科

基金项目:

湖北省卫生计生委资助项目(WJ2015MB224)；

详细信息

中图分类号: R575
计量
- 文章访问数: 2589
- HTML全文浏览量: 55
- PDF下载量: 411
- 被引次数: 18
出版历程
- 出版日期: 2017-06-20

Value of serum PCT in early diagnosis of bacterial infection in patients with liver failure

Research funding:

摘要

摘要:
目的探讨血清降钙素原（PCT）检测对于肝衰竭合并感染早期诊断的价值。方法选取2014年1月-2014年12月十堰市太和医院463例乙型肝炎患者,按肝功能指标分为轻度肝损伤组（n=120）、中度肝损伤组（n=222）、重度肝损伤组（n=53）和肝衰竭组（n=68）,对各组PCT水平进行检测,对肝衰竭患者进一步测定WBC、高敏C反应蛋白（hs CRP）并观察临床表现。计量资料符合正态分布组间比较采用t检验,不符合正态分布的多组间比较采用Kruskal-Wallis H检验,组间两两比较采用Mann-Whitney U检验;计数资料组间比较采用χ2检验;预测分析采用受试者工作特征曲线（ROC曲线）法。结果肝衰竭组PCT水平[0.81（0.342.15）]明显高于重度肝损伤组[0.53（0.211.59）]、中度肝损伤组[0.35（0.101.18）]及轻度肝损伤组[0.17（0.100.60）],组间比较差异有统计学意义（χ2=25.091,P<0.05）。肝衰竭患者中PCT<0.25 ng/...
- 肝功能衰竭 /
- 降钙素原 /
- 感染
Abstract:
Objective To investigate the value of serum procalcitonin (PCT) in early diagnosis of bacterial infection in patients with liver failure. Methods A total of 463 patients with hepatitis B were selected from January to December, 2014, in the Department of Infectious Diseases, Taihe Hospital. According to the degree of liver injury, the patients were divided into four groups: mild liver injury group (n =120) , moderate liver injury group (n = 222) , sever liver injury group (n = 53) , and liver failure group (n = 68) . Serum PCT was measured for all patients, and the white blood cell count (WBC) and high-sensitivity C-reactive protein (hs CRP) were measured for patients with liver failure. The clinical manifestations were observed and recorded. The t test was used for comparison of normally distributed continuous data, while the Kruskal-Wallis H test was used for non-normally distributed continuous data; the Mann-Whitney U test was used for pairwise comparison of continuous data. The chi-square test was used for comparison of categorical data. The receiver operating characteristic (ROC) curve was used for the analysis of predictive value. Results The liver failure group had a significantly higher PCT level than the severe liver injury group, moderate liver injury group, and mild liver injury group (0. 81[0. 34-2. 15] vs 0. 53[0. 21-1. 59 ], 0. 35[0. 10-1. 18], and 0. 17[0. 10-0. 60], χ2= 25. 091, P < 0. 05) . The liver failure patients with PCT levels of < 0. 25 ng/ml (n = 10) , 0. 25-0. 5 ng/ml (n = 10) , and > 0. 5 ng/ml (n = 48) had infection rates of 20%, 30%, and 66. 7%, respectively, with a significant difference between the patients with a PCT level of > 0. 5 ng/ml and those with PCT levels of < 0. 25 ng/ml and 0. 25-0. 5 ng/ml (χ2=5. 631, 4. 650, P = 0. 018, 0. 031) . Among the liver failure patients, the infection cases had significantly higher PCT, WBC, and hs CRP than the non-infection cases (PCT: 3. 72 ± 1. 33 ng/ml vs 0. 34 ± 0. 12 ng/ml, t =-2. 547, P = 0. 015; hs CRP: 16. 70 ± 7. 03 mg/L vs11. 00 ± 6. 52 mg/L, t =-3. 458, P = 0. 001) ; the hs CRP level in both infection and non-infection cases was higher than the normal value, and the WBC in both infection and non-infection cases was lower than the normal value. In the 37 liver failure patients with infection, 13 (35. 14%) had no symptoms and signs associated with infection, but had significantly increased serum PCT. As for the predictive value of PCT for bacterial infection, the area under the ROC curve was 0. 691, with a sensitivity of 0. 737 and a specificity of 0. 700. Conclusion The patients with liver failure are susceptible to bacterial infection. Serum PCT measurement has great significance for early diagnosis of bacterial infection in patients with liver failure.
- liver failure /
- procalcitonin /
- infection

HTML全文

参考文献(19)

[1]Ol SON JC, KAMATH PS.Acute-on-chronic liver failure:what are the implication?[J].Curr Gastroenterol Rep, 2012, 14 (1) :63-66.

[2] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA;Severe Liver Disease and Artificial Liver Group, Chinese Sociely of Hepatology, CMA.Guideline for diagnosis and treatment of liver failure (2012 version) [J].Chin J Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.

[3]BONNEL AR, BUNCHORNTAVAKUL C, REDDY KR.Immune dysfunction and infections in patients with cirrhosis[J].Clin Gastroenteraol Hepatol, 2011, 9 (9) :727-738.

[4]LEBER B, SPINDELBOECK W, STADLBAUE V.Infectious complications of acute and chronic liver disease[J].Semin Respir Crit Care Med, 2012, 33 (1) :80-95.

[5]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[6]Chinese Society of Infectious Diseases, Parasitology, and Hepatology.Plans for prevention and treatment of virus hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.

[7]European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J].J Hepatol, 2010, 53 (3) :397-417.

[8] Editorial board of Chinese Journal of Digestion, Consensus opinion on Chinese medical diagnosis and treatment of Chronic cholecystitis and cholecystolithiasis[J].Chin J Dig, 2014, 34 (12) :795-799. (in Chinese) 中华消化杂志编辑委员会.中国慢性胆囊炎、胆囊结石内科诊疗共识意见[J].中华消化杂志, 2014, 34 (12) :795-799.

[9] Biliary Surgery Group, Surgery Branch of Chinese Medical Association.Diagnosis and treatment guidelines for acute biliary infection (2011 edition) [J].Chin J Dig Surg, 2011, 10 (1) :9-13. (in Chinese) 中华医学会外科学分会.急性胆道系统感染的诊断和治疗指南 (2011年版) [J].中华消化外科杂志, 2011, 10 (1) :9-13.

[10]GE JB, XU YJ.Internal medicine[M].8th.Beijing:People's Medical Publishing House, 2013. (in Chinese) 葛均波, 许永键.内科学[M].第8版.北京:人民卫生出版社, 2013.

[11]ZHENG JF, CAI ZH, ZHANG X, et al.Value of single or combined measurement of serum PCT, peripheral WBC, and WBC/PCT for early diagnosis of bacterial infection in patients with liver cirrhosis[J].J Clin Hepatol, 2015, 31 (2) :209-213. (in Chinese) 郑俊福, 蔡照华, 张鑫, 等.降钙素原和外周血白细胞/血小板单独或联合检测对肝硬化合并细菌感染患者早期诊断的价值[J].临床肝胆病杂志, 2015, 31 (2) :209-213.

[12]JIN YN.Expression of serum procalcitonin in senile patients with severe pulmonary infection[J].Clin J Med Offic, 2016, 44 (6) :640-642. (in Chinese) 金玉女.血清降钙素原水平在老年重症肺部感染诊断中意义[J].临床军医杂志, 2016, 44 (6) :640-642.

[13]GARNACHO-MONTERO J, HUICI-MORENO MJ, GUTIERREZ-PIZARRAYA A, et al.Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically III patients admitted with suspicion of sepsis[J].Crit Care, 2014, 18 (3) :r116.

[14]WEI XP, GAO X, MA YJ.Relationship between small intestinal bacterial overgrowth and severity of with hepatitis B cirrhosis[J].J Clin Hepatol, 2016, 32 (4) :716-719. (in Chinese) 魏新朋, 高晓, 马英杰.乙型肝炎肝硬化患者小肠细菌过度生长与疾病严重程度的相关性[J].临床肝胆病杂志, 2016, 32 (4) :716-719.

[15]ARAI T, KUMASAKA K, NAGATA K, et al.Prediction of blood culture results by measuring procaleitonin levels and other inflammatory biomarkers[J].Am J Emerg Med, 2014, 32 (4) :330-333.

[16]REINHART K, MEISNER M.Biomarkers in the critically ill patient:procalcitonin[J].Crit Care Clin, 2011, 27 (2) :253-263.

[17]LI XY, ZHU YJ, ZHANG SP, et al.Risk factors and infection characteristics in patients with chronic severe hepatitis B[J].Chin J Nosocomiol, 2009, 19 (6) :644-646. (in Chinese) 厉小玉, 朱以军, 章松平, 等.慢性重型乙型病毒性肝炎患者医院感染特点及相关危险因素分析[J].中华医院感染学杂志, 2009, 19 (6) :644-646.

[18]ZHANG Y, ZHANG ZG.Clinical value of procalcitonin and C-reactive protein test in liver cirrhotic patients with spontaneous bacterial peritonitis[J].Clin Focus, 2010, 25 (8) :665-668. (in Chinese) 张颖, 张志广.肝硬化合并自发性腹膜炎患者降钙素原和C反应蛋白检测的临床意义[J].临床荟萃, 2010, 25 (8) :665-668.

[19]WIWATCHARAGOSES K, KINGNAKOM A.Procalcitonin under investigation as a means of detecting severe sepsis, septic shock and bacteremia at emergency department, rajavithi hospital[J].Med Assoc Thai, 2016, 99 (Suppl 2) :63-68.

施引文献

期刊类型引用(17)

1.	郭堑，农村立，韦秋芳. 慢性乙型肝炎肝纤维化患者血清Copeptin和PCT表达水平及其临床价值研究. 现代检验医学杂志. 2023(02): 112-117+189 . 百度学术
2.	李初谊，王俊科，李斌，温雪，魏晓静，于晓辉. 血浆置换对慢加急性肝衰竭辅助治疗的效果评价. 海南医学院学报. 2022(16): 1228-1231 . 百度学术
3.	王鑫，张国民，牛兴杰，李萍，张冰. 外周血CD14~+CD16~+单核细胞亚群在肝衰竭继发感染患者中的检测价值. 中国免疫学杂志. 2020(09): 1124-1127+1130 . 百度学术
4.	姜曼蕾，许飞，胡江玲，罗嘉裕，罗方云. IL-6、CRP、PCT和内毒素预判肝衰竭合并细菌感染风险中的临床价值. 中华医院感染学杂志. 2020(20): 3062-3065 . 百度学术
5.	张国民，王鑫，韩智炜，牛兴杰，刘志慧，崔凤梅. 降钙素原、白细胞介素6、sCD14、CD64检测在肝功能衰竭患者诊治中的临床研究. 中国现代医学杂志. 2019(03): 47-51 . 百度学术
6.	江艳霞，骆小燕，骆旭航，龚安安，孙爱华. 血清降钙素原在胆管炎危重度早期评估中的价值研究. 中国卫生检验杂志. 2019(04): 462-463+468 . 百度学术
7.	张国民，韩智炜，牛兴杰，刘志慧，王鑫. IL-6、CD14、CD64检测在感染所致肝衰竭患者中意义. 现代医学. 2019(02): 137-140 . 百度学术
8.	黄波，张炜. 喜炎平注射液联合还原型谷胱甘肽治疗重症烧伤后急性肝功能损伤临床研究. 创伤与急危重病医学. 2019(03): 156-159 . 百度学术
9.	杨丽霞，张伦理，赖玲玲，方铭. 腹水中肝素结合蛋白及降钙素原对肝硬化腹水伴自发性细菌性腹膜炎的诊断价值. 临床肝胆病杂志. 2019(06): 1266-1269 . 本站查看
10.	李薇，任小丹，何谦，周荣幸. 血清降钙素原检测对胆道梗阻合并感染者的预测价值. 中华实验和临床感染病杂志(电子版). 2019(03): 245-249 . 百度学术
11.	张国民，韩智炜，牛兴杰，刘志慧，崔凤梅，王鑫. PCT、IL-6、CD14、CD64及TNF-α表达对肝衰竭合并医院感染患者预后的影响. 中华医院感染学杂志. 2019(16): 2450-2453 . 百度学术
12.	王鑫，张国民，牛兴杰，李萍，张冰. 肝衰竭继发感染患者外周血Toll样受体4及降钙素原、C反应蛋白变化情况分析. 现代消化及介入诊疗. 2019(10): 1084-1087+1094 . 百度学术
13.	石春霞，陈倩，王瑶，焦方舟，龚作炯. 肝功能衰竭并感染患者血清正五聚蛋白3和肝素结合蛋白及降钙素原水平变化. 中华实用诊断与治疗杂志. 2019(12): 1188-1190 . 百度学术
14.	顾静，王艳，陈丽，徐英，甘建和. HBV相关慢加急性肝衰竭患者血清IL-32和IL-10水平变化及意义. 临床肝胆病杂志. 2018(04): 801-805 . 本站查看
15.	王小芳，奉万盛，周红翠，邱咏佳. 血清降钙素原、白细胞计数、C-反应蛋白与细菌血培养联合检测在感染患者中的应用价值. 中国医药导报. 2018(19): 75-78 . 百度学术
16.	沈素晶，邓超，李霭文，谭俊青. 不同化学发光检测系统测定PCT结果的相关性分析. 实验与检验医学. 2018(06): 873-875+891 . 百度学术
17.	詹金美，林欢，孙家敏. 定量检测血清降钙素原在诊断肝衰竭患者腹腔感染细菌类型中的价值. 中外医疗. 2017(28): 34-36 . 百度学术